BioCentury
ARTICLE | Financial News

Lorantis raises $16.5 million

April 20, 2001 7:00 AM UTC

Immunological and inflammatory disease company Lorantis ( Cambridge, U.K.) closed an 11.5 million ($16.5 million) second round financing lead by JP Morgan with one new investor, Quester Capital, joini...